Mohamed Y Ismail

This inventor holds 19 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Paratek Pharmaceuticals, Inc., Tufts University, Perseptive Biosystems Inc.. Active years: 2000-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohamed Y Ismail. Retrieved from https://idiyas.com/inventor/mohamed-y-ismail

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 8)

% Patents Active = 31.6

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 22)

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 279(Granted Patents)

Company Filing History:

15 out of 71

Paratek Pharmaceuticals, Inc.

Perseptive Biosystems Inc.

patents

4. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2016

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9365500 - 9-aminomethyl substituted minocycline compounds (2016-06-14),

2. 8492365 - 7-substituted tetracycline compounds (2013-07-23),

3. 8481513 - 3, 10, and 12a substituted tetracycline compounds (2013-07-09),

4. 8470804 - 11a, 12-derivatives of tetracycline compounds (2013-06-25),

5. 8466132 - Substituted tetracycline compounds (2013-06-18),

6. 8258120 - 9-substituted minocycline compounds (2012-09-04),

7. 8119622 - 7-phenyl-substituted tetracycline compounds (2012-02-21),

8. 8088755 - 11a, 12-derivatives of tetracycline compounds (2012-01-03),

9. 8048867 - 9-substituted minocycline compounds (2011-11-01),

10. 7858600 - 7- and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds (2010-12-28),

11. 7825105 - 3, 10, and 12a substituted tetracycline compounds (2010-11-02),

12. 7696186 - 7,9-substituted tetracycline compounds (2010-04-13),

13. 7595309 - 7-substituted tetracycline compounds (2009-09-29),

14. 7553828 - 9-aminomethyl substituted minocycline compounds (2009-06-30),

15. 7326696 - Amino-methyl substituted tetracycline compounds (2008-02-05),

Title: The Innovative Mind of Mohamed Y Ismail

Introduction

Mohamed Y Ismail, an accomplished inventor based in Bedford, MA, has made significant contributions to the field of medicine through his innovative patents. With 17 patents to his name, he has focused on developing novel compounds that aid in the treatment of various medical conditions.

Latest Patents

Among his latest innovations are two groundbreaking patents centered on minocycline and tetracycline compounds. The first, addressing 9-aminomethyl substituted minocycline compounds, highlights novel compounds that can be utilized in treating bacterial infections, neoplasms, and other tetracycline compound-responsive states. These compounds are known for their ability to block tetracycline efflux and modulate gene expression, making them a vital addition to medical treatments.

The second, focusing on 7-substituted tetracycline compounds, shares similar therapeutic applications. This invention presents novel 7-substituted tetracycline compounds aimed at combating bacterial infections and neoplasms, showcasing the continued significance of tetracycline in medical treatments.

Career Highlights

Throughout his career, Mohamed Y Ismail has worked for notable organizations such as Paratek Pharmaceuticals, Inc. and Tufts College. His tenure in these institutions has allowed him to collaborate with other experts and work on innovative research that has broadened the horizons of medical science.

Collaborations

Ismail has had the privilege of collaborating with remarkable colleagues, including Mark L Nelson and Todd Bowser. These collaborations have undoubtedly contributed to the creation of significant innovations in the field and underscore the importance of teamwork in achieving groundbreaking advancements.

Conclusion

Mohamed Y Ismail's contributions to the fields of medicine and patent innovation are noteworthy, with 17 patents showcasing his commitment to improving health outcomes. His pioneering work with minocycline and tetracycline compounds exemplifies the importance of innovation in combating medical challenges, making him a distinguished figure in the realm of inventors and patent holders.

Profile summary based on public USPTO records.